Condensed Consolidated Statements Of Cash Flows (USD $) In Millions, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows - operation activities:
Net earnings	$ 965	$ 1,106
Non-cash items –
Share-based plans expense	52	58
Depreciation and amortization	448	429
Investment/asset impairment charges, net	29	26
Customer financing valuation benefit	(23)	(3)
Gain on disposal of discontinued operations	(1)
Gain on dispositions, net		(22)
Other charges and credits, net	47	53
Excess tax benefits from share-based payment arrangements	(68)	(23)
Changes in assets and liabilities –
Accounts receivable	(792)	(437)
Inventories, net of advances and progress billings	(2,049)	(3,000)
Accounts payable	1,350	654
Accrued liabilities	(1,385)	(1,133)
Advances and billings in excess of related costs	1,085	1,833
Income taxes receivable, payable and deferred	455	214
Other long-term liabilities	(124)	(73)
Pension and other postretirement plans	733	821
Customer financing, net	408	24
Other	(18)	(3)
Net cash provided by operating activities	1,112	524
Cash flows – investing activities:
Property, plant and equipment additions	(497)	(521)
Property, plant and equipment reductions	15	33
Acquisitions, net of cash acquired		(26)
Contributions to investments	(2,737)	(2,955)
Proceeds from investments	3,625	2,655
Net cash provided/(used) by investing activities	406	(814)
Cash flows – financing activities:
New borrowings	51	15
Debt repayments	(757)	(1,262)
Payments to noncontrolling interests	(12)
Repayments of distribution rights and other asset financing	(3)	(138)
Stock options exercised, other	109	76
Excess tax benefits from share-based payment arrangements	68	23
Employee taxes on certain share-based payment arrangements	(84)	(52)
Common shares repurchased	(2,500)
Dividends paid	(540)	(367)
Net cash used by financing activities	(3,668)	(1,705)
Effect of exchange rate changes on cash and cash equivalents	4	(11)
Net decrease in cash and cash equivalents	(2,146)	(2,006)
Cash and cash equivalents at beginning of year	9,088	10,341
Cash and cash equivalents at end of period	$ 6,942	$ 8,335